A new mouse study reveals a drug compound is effective at treating and potentially reversing symptoms of Fragile x syndrome. Read More
Non-invasive auricular transcutaneous vagus nerve stimulation (atVNS), applied to an accessible area of the ear, improves memory in mouse models of intellectual disability. Read More
Stem cell study reveals a genetic defect associated with fragile X syndrome delays the production of neurons during a critical stage of embryonic development. Read More
Lovastatin, a common statin usually prescribed to control cholesterol, corrected learning and memory deficits associated with Fragile X syndrome in rodent models. Read More
Researchers have identified a specific mechanism involved in how females inherit traits. The findings could help reduce susceptibility to Fragile X and Rett syndrome, the researchers report. Read More
Researchers report functional alterations in L-type calcium channels were detected in models of Fragile X syndrome. Read More
Researchers have successfully reduced some symptoms associated with fragile X syndrome in mice with the help of CRISPR-Cas 9 gene editing. Read More
According to researchers, a drug approved by the FDA may reverse some of the symptoms associated with Fragile X syndrome. The drug can reverse hyper-excitability that leads to sensory hypersensitivity. Read More
Researchers have derived purkinje cells from patients with TSC, a genetic syndrome that includes some ASD-like symptoms. The cells, researchers say, have several characteristics that could help explain how ASD develops at the molecular level. Read More
Researchers report neurons in mice with a genetic defect that causes Fragile X are similar to those in mice without the syndrome, but fail to interact correctly. This failure results in the cognitive impairment associated with FXS. Read More
Researchers have identified a molecular mechanism that contributes to a slowed maturation of fast spiking neurons. The developmental delay has been implicated in Fragile X. However, researchers were able to restore normal maturation speed by administering an activator of the TrkB protein. Read More
According to researchers, treatment that target chromatin remodelers may provide new avenues of treatment for Fragile X Syndrome and other autism spectrum disorders. Read More
